Schmertzler Michael's Form 4 filing
PTC Therapeutics, Inc.PTCT · filed Aug 21, 2026
- Accession no.
- 0001288952-26-000004
- Filed
- Aug 21, 2026, 5:20 PM ET
- Trade date
- Aug 19-20, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions. Open-market sales total $1.81M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schmertzler MichaelCIK 0001288952 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Common Stock | SSaleDisposed | −5,335 | $72.86F2 | −$388,708.1 | 1,381,259 | Indirect | |
| Aug 19, 2026 | Common Stock | SSaleDisposed | −7,165 | $73.67F4 | −$527,845.55 | 1,374,094 | Indirect | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −9,419 | $70.78F5 | −$666,676.82 | 1,364,675 | Indirect | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −2,390 | $71.88F6 | −$171,793.2 | 1,362,285 | Indirect | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −691 | $72.92F7 | −$50,387.72 | 1,361,594 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $72.33 to $73.32 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $73.33 to $74.02 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $70.50 to $71.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $71.50 to $72.46 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $72.60 to $73.48 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.